ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO058

Overexpression of Preeclampsia Induced miR-26a-5p Leads to Proteinuria in Zebrafish

Session Information

Category: Glomerular

  • 1001 Glomerular: Basic/Experimental Immunology and Inflammation

Authors

  • Müller-Deile, Janina, Hannover medical school, Hanover, Germany
  • Schroder, Patricia Ann, Mount Desert Island Biological Laboratory, Salisbury Cove, Maine, United States
  • Nystrom, Jenny C., University of Gothenburg , Goteborg, Sweden
  • Haller, Hermann G., Hannover Medical School, Hannover, Germany
  • Schiffer, Mario, Hannover Medical School, Hannover, Germany
Background

So far the pathomechanism of preeclampsia in pregnancy is focussed on increased circulating levels of sFLT1 that neutralizes glomerular VEGF-A expression and prevents its signalling at the glomerular endothelium. MiR-26a-5p is upregulated in the preeclamptic placenta.

Methods

We analyzed miR-26a-5p expression in podocytes and microinjected zebrafish eggs with a miR-26a-5p mimic. We analysed phenotype, proteinuria and ultrastructural changes of the glomerular filtration barrier.

Results

We found that miR-26a-5p targets VEGF-A expression in cultured podocytes and that its overexpression in zebrafish causes proteinuria, edema, glomerular endotheliosis and podocyte foot process effacement. Recombinant zebrafish vegf-Aa protein could rescue glomerular changes induced by miR-26a-5p. Preeclamptic patients with podocyte damage identified by podocyturia, expressed significantly more urinary miR-26a-5p compared to controls.

Conclusion

Thus, functional and ultrastructural glomerular changes after miR-26a-5p overexpression can resemble the findings seen in preeclampsia and indicate a potential pathophysiological role of miR-26a-5p in addition to sFLT-1 in this disease.